Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+282K
-
Total reported value, excl. options
-
$42.5M
-
Value change
-
+$985K
-
Put/Call ratio
-
0.6
-
Number of buys
-
14
-
Number of sells
-
-8
-
Price
-
$3.85
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q1 2022
34 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q1 2022.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
of 134M outstanding shares and own 8.26% of the company stock.
Largest 10 shareholders include Oasis Management Co Ltd. (3.53M shares), RENAISSANCE TECHNOLOGIES LLC (2.69M shares), Man Group plc (1.8M shares), BlueCrest Capital Management Ltd (1.45M shares), Qube Research & Technologies Ltd (449K shares), Quinn Opportunity Partners LLC (324K shares), BANK OF AMERICA CORP /DE/ (221K shares), NATIXIS ADVISORS, L.P. (189K shares), Parametric Portfolio Associates LLC (97.7K shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (44K shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.